The Current Ratio as of December 2025 (TTM) for Barinthus Biotherapeutics plc (BRNS) is 8.04

According to Barinthus Biotherapeutics plc’s latest financial reports and current stock price. The company's current Current Ratio is 8.04. This represents a change of -2.98% compared to the average of 8.28 of the last 4 quarters.

Barinthus Biotherapeutics plc (BRNS) Historical Current Ratio (quarterly & annually)

How has BRNS Current Ratio performed in the past?

The mean historical Current Ratio of Barinthus Biotherapeutics plc over the last ten years is 11.22. The current 8.04 Current Ratio has changed 7.06% with respect to the historical average. Over the past ten years (40 quarters), BRNS's Current Ratio was at its highest in in the September 2021 quarter at 38.60. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Barinthus Biotherapeutics plc (BRNS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Barinthus Biotherapeutics plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Barinthus Biotherapeutics plc (BRNS) Average Current Ratio

How has BRNS Current Ratio performed in the past?

The current Current Ratio of Barinthus Biotherapeutics plc (BRNS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Barinthus Biotherapeutics plc (BRNS) Current Ratio vs. Peers

How is BRNS’s Current Ratio compared to its peers?

Barinthus Biotherapeutics plc’s Current Ratio is greater than CEL-SCI Corporation (0.47), greater than Karyopharm Therapeutics Inc. (1.03), greater than INmune Bio, Inc. (4.17), greater than Senti Biosciences, Inc. (1.51), greater than Mersana Therapeutics, Inc. (1.39), greater than Aligos Therapeutics, Inc. (4.70), less than OnKure Therapeutics, Inc. (11.45), greater than Medicus Pharma Ltd. Common Stock (0.92), greater than Tempest Therapeutics, Inc. (2.11), greater than Kezar Life Sciences, Inc. (7.29),

Build a custom stock screener for Barinthus Biotherapeutics plc (BRNS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Barinthus Biotherapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Barinthus Biotherapeutics plc (BRNS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Barinthus Biotherapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.